What is the current Price Target for the Unicycive Therapeutics Inc stock?

The average Unicycive Therapeutics Inc target price is $25.50. This is 430.15% higher than the current stock price. The highest price target is 991.48%, the lowest is 214.97%. 11 Analysts have issued a price target Unicycive Therapeutics Inc 2027 .

How high will the Unicycive Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Unicycive Therapeutics Inc stock will rise. The performance of stocks, including the Unicycive Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Unicycive Therapeutics Inc stock today?

The performance of Unicycive Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Unicycive Therapeutics Inc stock fall?

The decline in Unicycive Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Unicycive Therapeutics Inc Forecast, price target & analysts

$4.81

0.00%

Nasdaq, Sep 24, 04:01 pm EDT. Closed.

ISIN

US90466Y1038

Symbol

UNCY

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Unicycive Therapeutics Inc Target price 2026 - Analyst rating & recommendation

Unicycive Therapeutics Inc Classifications & Recommendation

Buy

93%

Hold

Unicycive Therapeutics Inc Price Target

Target Price	$25.50
Price	$4.81
Potential	430.15% register free of charge
Number of Estimates	11

	11 Analysts have issued a price target Unicycive Therapeutics Inc 2027 . The average Unicycive Therapeutics Inc target price is $25.50. This is 430.15% register free of charge higher than the current stock price. The highest price target is $52.50 991.48% register free of charge , the lowest is $15.15 214.97% register free of charge .
	A rating was issued by 15 analysts: 14 Analysts recommend Unicycive Therapeutics Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Unicycive Therapeutics Inc stock has an average upside potential 2027 of 430.15% register free of charge . Most analysts recommend the Unicycive Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
P/E		negative
EV/Sales		193.72

11 Analysts have issued a Unicycive Therapeutics Inc forecast for earnings per share. The average Unicycive Therapeutics Inc EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2027	$1.80 238.46% unlock
2028	$10.05 458.33% unlock
2029	$8.34 17.01% unlock
2030	$8.02 3.84% unlock
2031	$7.98 0.50% unlock
2032	$5.22 34.59% unlock
2033	$4.18 19.92% unlock

Current
2026	-3.69 0.27% unlock
2027	2.67 172.36% unlock
2028	0.48 82.02% unlock
2029	0.58 20.83% unlock
2030	0.60 3.45% unlock
2031	0.60 0.00% unlock
2032	0.92 53.33% unlock
2033	1.15 25.00% unlock

Unicycive Therapeutics Inc...

Current Unicycive Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Benchmark	Locked ➜ Locked	Locked	Aug 20 2026
B. Riley Securities	Locked ➜ Locked	Locked	Aug 13 2026
Guggenheim	Locked ➜ Locked	Locked	Aug 13 2026
Noble Capital Markets	Locked ➜ Locked	Locked	Jul 01 2026
Benchmark	Locked ➜ Locked	Locked	Jul 01 2026
B. Riley Securities	Locked ➜ Locked	Locked	Jun 30 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jun 30 2026

Analyst Rating	Date
Locked Benchmark: Locked ➜ Locked	Aug 20 2026
Locked B. Riley Securities: Locked ➜ Locked	Aug 13 2026
Locked Guggenheim: Locked ➜ Locked	Aug 13 2026
Locked Noble Capital Markets: Locked ➜ Locked	Jul 01 2026
Locked Benchmark: Locked ➜ Locked	Jul 01 2026
Locked B. Riley Securities: Locked ➜ Locked	Jun 30 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Jun 30 2026

Discover more stocks with a high price target

NIO ADR 101.75%

Alibaba Group Holding Ltd 67.67%

Tencent Holdings Ltd. 55.89%

Uber Technologies 48.83%

Siemens Energy 47.15%

Adidas 46.64%

BYD 44.49%

Deutsche Telekom 38.45%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now